Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis.

PloS one - 1 Jan 2020

Abe Kazumichi, Wakabayashi Hiroto, Nakayama Haruo, Suzuki Tomohiro, Kuroda Masahito, Yoshida Naoe, Tojo Jun, Kogure Atsuko, Rai Tsuyoshi, Saito Hironobu, Mukai Shinji, Fujita Masashi, Hayashi Manabu, Takahashi Atsushi, Ohira Hiromasa

Abstract excerpt

The present study aimed to investigate the incidence of hepatocellular carcinoma (HCC) and factors related to HCC occurrence after direct-acting antiviral (DAA) treatment in the Fukushima Liver Academic Group (FLAG). We conducted a multicenter retrospective cohort study of 1068 patients without cirrhosis (NC) or with compensated liver cirrhosis (LC) who achieved a sustained virologic response (SVR). First, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Diabetes Complications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Liver Cirrhosis

Share to Proportional Hazards Models

Share to Serum Albumin

Share to Survival Rate

Share to Sustained Virologic Response

Source

Open in PubMed Open full text

Identifiers

PMID: 33284844
DOI: 10.1371/journal.pone.0243473
PMCID: PMC7721183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis.PMID 33284844Read ↗

Epidemiology of viral hepatitis and hepatocellular carcinoma.Semantic proximity Read ↗

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.Semantic proximity Read ↗

Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.Semantic proximity Read ↗

DIRECT-ACTING ANTIVIRALS FOR HEPATITIS C DO NOT AFFECT THE RISK OF DEVELOPMENT OR THE OUTCOME OF HEPATOCELLULAR CARCINOMA.Semantic proximity Read ↗

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience.Semantic proximity Read ↗

Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens.Semantic proximity Read ↗

Hepatitis C virus-induced hepatocellular carcinoma: a narrative review.Semantic proximity Read ↗

Risk of hepatocellular carcinoma development in cases of hepatitis C treated by long-term, low-dose PEG-IFNα-2a.Semantic proximity Read ↗

Causes of Death in Hepatocellular Carcinoma Patients: A SEER-Based StudySemantic proximity Read ↗

Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of EpigeneticsSemantic proximity Read ↗

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.Semantic proximity Read ↗

New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirinSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.